About this trial

The Investigators will create a clinical database and a Biobank of stem cells derived from the blood of participants with cardiovascular disease. The Investigators will recruit participants from diverse racial and ethnic backgrounds with equal representation from both sexes. The Investigators expect to create stem cells and analyze the blood for protein biomarkers and genetic causes of cardiovascular disease. The stem cell biobank and clinical data will be a powerful tool for studying cardiovascular disease.

Eligibility criteria

Qualifiers

Adult (18 to 80 years of age)

Cardiovascular Disease (CVD)

Cerebrovascular Disease (CBD)

Peripheral Vascular Disease (PVD)

Disqualifiers

Younger than 18 years of age.

Patients not able to provide consent.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

200 Participants
are grouped into 2 trial groups

Locations

1
London Regional Health Science CentreN6A 5A5, LondonOntario, Canada

Sponsors and collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Lead sponsor

Greenstone Biosciences, Inc.

Collaborator